At the SPAC of Dawn September’s busy, but short, first week is set to keep rolling with three completion votes by Achari I (OTC:AVHI), Nova Vision (NASDAQ:NOVV) and Focus Impact (NASDAQ:FIAC) this week. All three of these have been postponed at least once, and could do so again, but Focus Impact has its transaction deadline...
Terms Tracker for the Week Ending September 6, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. It was a short holiday week and while it was light on filings, SPACs did manage to price two IPOs. That means 2024 has now...
Compass Digital (NASDAQ:CDAQ) has entered into a definitive agreement to combine with renewable energy firm EEW at a pro forma enterprise value of $386 million. London-based EEW is a solar, hydrogen and energy storage project developer with 1.4 GW of solar projects sold to date in Australia, the UK, Spain, and Sweden. The combined company...
Evergreen (NASDAQ:EVGR) has entered into a definitive agreement to combine with enterprise software firm Forekast at a pre-money enterprise value of $105 million. The company provides data analytics and customer engagement tools backed by some degree of AI automation to improve efficiencies for its business clients. The combined company is expected to trade on the...
Vine Hill Capital Investment Corp. announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VCICU”, Friday, September 6, 2024. The new SPAC intends to focus its search on a target business in the industrial and services industries, where it believes the expertise...
Andretti Acquisition Corp. II announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “POLEU”, Friday, September 6, 2024. The new SPAC intends to mount a broad search for a target with an attractive financial profile and a seasoned management team. Andretti II’s...
Keen Vision (NASDAQ:KVAC) has entered into a definitive agreement to combine with clinical-stage biotech firm Medera at an enterprise value of $622.6 million. Boston-based Medera is developing a line of gene therapies to potentially treat rare cardiovascular ailments. The combined company is expected to trade on the Nasdaq once the deal is completed in the...
Denali Capital (NASDAQ:DECA) has entered into a definitive agreement to combine with Semnur Pharmaceuticals at an equity value of $2.5 billion. Palo Alto, California-based Semnur is developing a non-opioid injectable pain treatment for lower back disorders. The combined company is expected to trade on the Nasdaq under the symbol “SMNR” once the deal is completed...
As the summer continues to heat up, so do trust accounts that seem to be lighting themselves on fire, leaving teams scrambling to secure as much of the remaining trust account as possible. August brings us a continuation of the summer with old and new SPACs both fighting for the same end goal. Extension Votes...
PowerUP (NASDAQ:PWUP) has entered into a definitive agreement to combine with Aspire Biopharma for $316.8 million in share compensation. Humacao, Puerto Rico-based is developing a method of administering aspirin more quickly with an oral powder as opposed to traditional pills. The combined company is expected to trade on the Nasdaq under the symbol “ASPH” once...